News
FDA UpdatesLaw and AdvocacyTechnology TrendsViewpointsAll News
Media
In-Depth InsightsPharmacist ViewScript-EdExpert InterviewsPodcasts
Conferences
Conference CoverageConference Listing
Resources
Disease Awareness White Board VideoAmerican Pharmacists MonthSponsored ResourcesCME/CEPartners
More
Publications
Drug Topics JournalTotal Pharmacy JournalSubmission of ArticlesSupplements And Featured Publications
Events
Virtual EventsTotal Pharmacy Solutions Summit
Business
Business StrategiesPatient ServicesPharmacy InventoryLaw and RegulationsTechnology and DataAll Business News
Practice Type
Independent PharmacyChain PharmacySpecialty PharmacyHealth System PharmacyPharmacy Technicians

Subscribe

  • News
  • Media
  • Conferences
  • Resources
  • Publications
  • Events
  • Business
  • Practice Type
  • Subscribe
  • Allergy
  • Autoimmune Diseases
  • Biosimilars
  • COVID-19
  • Cannabidiol (CBD)
  • Cardiology
  • Compounding
  • Continuous Glucose Monitoring
  • Dermatology
  • Diabetes
  • Digestive Health
  • Endocrinology
  • Eye Health
  • Generics
  • HIV
  • Headache and Migraine
  • Immunization
  • Infectious Disease
  • Influenza
  • Insulin Management
  • Medical Devices
  • Mental and Behavioral Health
  • Neurology
  • OTC
  • Obesity Management
  • Oncology
  • Pain Management
    • Nonopioid Pain Management
  • Pediatrics
  • Pneumococcal
  • Public Health
  • Rare Diseases
  • Respiratory
  • Rheumatology
  • Shingles
  • Specialty Pharmacy
  • Substance Use Disorder
  • Technology and Data
  • Veterinary Pharmacy
  • Women's Health
Spotlight -
NCPA Annual Convention|
American Pharmacists Month|
FDA Updates|
Pneumococcal
Advertisement

Kathleen Golebiewski

Advertisement

Articles by Kathleen Golebiewski

Divelisib

Duvelisib for Relapsed or Refractory CLL/SLL

ByLisa Holle, PharmD, BCOP, FHOPA,Kathleen Golebiewski
January 22nd 2019
Advertisement

Latest Updated Articles

  • Divelisib
    Duvelisib for Relapsed or Refractory CLL/​SLL

    Published: January 22nd 2019 | Updated:



Advertisement
Advertisement

Trending on Drug Topics

1

American Pharmacists Month: Students Seeking Both Common, Non-Traditional Pharmacy Careers

2

Pharmacists Improve Diabetes Outcomes Through Continuous Glucose Monitoring Services

3

FDA Approves Risperidone Injection for Bipolar I Disorder in Adults

4

Vaccine Messaging for Teens Should Tailor to Personal Perspectives

5

FDA Approves Afibercept-Boav as Biosimilar to Afibercept for Diabetic Macular Edema

  • About
  • Advertise
  • Editorial
  • Editorial Board
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • AdvanCE
  • Total Pharmacy
Drug Topics
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us